Leaderboards/Melanoma and MAPK Pathways

Melanoma and MAPK Pathways

Last updated June 1, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Jeffery S. Russell
Huntsman Cancer Institute
70
2
Pia Siljander
University of Helsinki
68
3
Tackhoon Kim
Korea University
61
4
Lu Si
Peking University
60
5
Yong Sun
Sichuan University
60
6
Liqun Li
Wenzhou Medical University
56
7
Xiaobo Li
Northern Jiangsu People's Hospital
54
8
Ran Gao
Chinese Academy of Medical Sciences & Peking Union Medical College
54
9
Chuanyuan Wei
Sun Yat-sen University
52
10
Fujiang Guo
Shanghai University of Traditional Chinese Medicine
52

Rising Stars Papers

1
Beyond basic characterization and omics: Immunomodulatory roles of platelet‐derived extracellular vesicles unveiled by functional testing
Journal of Extracellular Vesicles|2024
14 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Rupesh Paudel
Universitätsklinikum Würzburg
99
2
Islam E. Elkholi
Jewish General Hospital
99
3
Connor A. Ott
Thomas Jefferson University
84
4
Aalim Maqsood Bhat
Indian Institute of Integrative Medicine
84
5
Krystian Wdowiak
1 Military Clinical Hospital with Outpatient Clinic
63
6
Sourat Darabi
Hoag Memorial Hospital Presbyterian
63
7
Woo‐Jin Sim
Sejong University
59
8
Jiashe Chen
Tongji University
56
9
Vikas Yadav
Jawaharlal Nehru University
56
10
Nidhi Sharma
Science for Life Laboratory
56

Emerging Leaders Papers

1
Mapping the MOB proteins’ proximity network reveals a unique interaction between human MOB3C and the RNase P complex
Journal of Biological Chemistry|2023
5 cit.
2
Targeting the dependence on PIK3C3-mTORC1 signaling in dormancy-prone breast cancer cells blunts metastasis initiation
bioRxiv (Cold Spring Harbor Laboratory)|2023
1 cit.
3
Mapping the MOB proteins’ proximity network reveals a unique interaction between human MOB3C and the RNase P complex
bioRxiv (Cold Spring Harbor Laboratory)|2023
0 cit.
4
Anti-tumorigenic properties by trichothiodystrophy mutations in melanocytic cells
NAR Cancer|2025
0 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Levi A. Garraway
Broad Institute
99
2
Roger S. Lo
UCLA Jonsson Comprehensive Cancer Center
99
3
Boris C. Bastian
University of California, San Francisco
95
4
Deok Ryong Kim
Gyeongsang National University
91
5
Eric Van Cutsem
KU Leuven
85
6
Todd R. Golub
Eli and Edythe Broad Foundation
79
7
René Bernards
The Netherlands Cancer Institute
74
8
Dirk Schadendorf
Broad Institute
71
9
Jeff Settleman
Discovery Centre
70
10
Jeffrey A. Engelman
Tufts Medical Center
69

All-Time Leaders Papers

1
Distinct Sets of Genetic Alterations in Melanoma
New England Journal of Medicine|2005
2.7k cit.
2
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
Journal of Clinical Oncology|2015
2.1k cit.
3
Somatic Activation of KIT in Distinct Subtypes of Melanoma
Journal of Clinical Oncology|2006
1.6k cit.
4
Mutations in <i>GNA11</i> in Uveal Melanoma
New England Journal of Medicine|2010
1.5k cit.
5
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
Nature Medicine|2019
1.1k cit.
6
The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer
Cancer Discovery|2014
842 cit.
7
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Treatment and <i>RAS</i> Mutations in Colorectal Cancer
Journal of Clinical Oncology|2015
795 cit.
8
Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies
Signal Transduction and Targeted Therapy|2023
744 cit.
9
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
Nature Communications|2015
632 cit.
10
Melanoma whole-exome sequencing identifies V600EB-RAF amplification-mediated acquired B-RAF inhibitor resistance
Nature Communications|2012
620 cit.

Reagents for Melanoma and MAPK Pathways

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Recommended

Best all-around

Cell Signaling Technology

beta-Catenin (D10A8) Rabbit Monoclonal Antibody (PE Conjugate)

Cited in 20 papers
#14903$471
View Evidence →Cell Signaling Technology

COX IV (3E11) Rabbit Monoclonal Antibody (Alexa Fluor® 488 Conjugate)

Cited in 17 papers
#4853$465
View Evidence →Bio-Rad

Rabbit Anti-Rat MEK 5 Polyclonal antibody, Unconjugated

Cited in 17 papers
#AHP1302
View Evidence →

🌟 All-Time

Most validated

Roche

VENTANA® anti-BRAF V600E (VE1) Mouse Monoclonal Primary Antibody

Cited in 30 papers
#760-5095 (also 08033706001)
View Evidence →MedChemExpress

Phospho-BRAF (Thr401) Antibody

Cited in 24 papers
#HY-P80794
View Evidence →MedChemExpress

BRAF Antibody

Cited in 24 papers
#HY-P80572
View Evidence →